{
  "created_at": "Tue Aug 24 1:7:14 +0000 2021",
  "id_str": "1429962955916038148",
  "full_text": "RT @AndySwan: FDA APPROVAL requires Pfizer to submit study results analyzing risk of myocarditis and pericarditis, and risk to long-term inâ€¦",
  "display_text_range": [
    0,
    140
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [
      {
        "screen_name": "AndySwan",
        "name": "Swanstradomus",
        "id": 690823,
        "id_str": "690823",
        "indices": [
          3,
          12
        ]
      }
    ],
    "urls": []
  },
  "user": {
    "name": "The_Real_Fly",
    "screen_name": "The_Real_Fly",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/1365459205453471751/LL4GKo3m_normal.jpg"
  },
  "retweet_count": 1151,
  "favorite_count": 0,
  "original_created_at": "Tue Aug 24 00:25:10 +0000 2021",
  "retweeted_status": {
    "created_at": "Mon Aug 23 15:36:03 +0000 2021",
    "id_str": "1429829799309189120",
    "full_text": "FDA APPROVAL requires Pfizer to submit study results analyzing risk of myocarditis and pericarditis, and risk to long-term infant development in pregnant women.\n\nStudy results reports will be submitted to the FDA for review on Oct 31, 2025 and May 31, 2027 respectively.",
    "display_text_range": [
      0,
      270
    ],
    "entities": {
      "hashtags": [],
      "symbols": [],
      "user_mentions": [],
      "urls": []
    },
    "user": {
      "name": "Swanstradomus",
      "screen_name": "AndySwan",
      "profile_image_url_https": "https://pbs.twimg.com/profile_images/1400170494196920322/d_2WQXFb_normal.jpg"
    },
    "retweet_count": 1151,
    "favorite_count": 2300
  }
}